206650 — EuBiologics Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for EuBiologics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-60,134	-28,025	-3,437	-15,360	18,992
Depreciation
Amortisation
Non-Cash Items	52,337	23,121	9,053	25,993	19,507
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	934	-9,262	-7,057	6,650	-5,363
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-914	-7,602	6,440	26,452	43,212
Capital Expenditures	-9,938	-9,159	-25,236	-43,657	-11,817
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-5,306	-29,084	23,103	15,547	-15,180
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-15,245	-38,244	-2,132	-28,110	-26,998
Financing Cash Flow Items	2,677	1,031	717	1,779	138
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	63,581	-713	635	566	-3,811
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	47,421	-46,554	4,509	-1,147	12,957